MENU
RIGL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Rigel Pharmaceuticals (RIGL) Ownership - Who owns Rigel Pharmaceuticals?

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 650 624-1100
Employees
174
Web
https://www.rigel.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
556.54M
P/E Ratio
1.56
Total Cash
146.68M
Projected Growth
N/A
Total Debt
45.72M
Revenue
299.77M
Risk (Beta)
3.25
Dividend Yield
N/A
Total Cash/Share
7.93
Total Debt/Equity
N/A
Revenue/Share
15.60 USD as % of share price
View a ticker or compare two or three
RIGL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a clinical-stage drug development company that discovers and develops novel, small-molecule drugs

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 650 624-1100
Employees
174
Web
https://www.rigel.com